Bu derlemede hayvan ve insan sağlığında antibiyotiklere alternatif olarak kullanılmakta olan probiyotiklerin etkileri ve güvenilirlikleri ile beraber probiyotik olarak kullanılan mikroorganizmalar ve bu mikroorganizmalarda aranan özellikler hakkında bilgi verilmiştir.
1. Başyiğit G, (2004). Bazı laktik asit bakterilerinin probiyotik
olarak kullanılma özellikleri. Süleyman Demirel
Üniversitesi Fen Bilimleri Enstitüsü Gıda Mühendisliği
Anabilim Dalı Yüksek Lisans Tezi, 96s, Isparta.
2. Castagliuolo LM, Riegler MF, Valenick I, La Mont JT,
Pathoulakis C, (1999). Saccharomyces boulardii; protease
inhibits the effects of Clostridium difficile toxins A and B in
human colonic mucosa. Infect Immun. 67, 302-307.
3. Douglas LC, Sanders ME, (2008). Probiotics and prebiotics
in dietetics practice. J Am Dietetic Assoc. 108, 510-521.
4. Dunne C, Murphy L, Flynn S, O’Mahony L, O’Halloran S,
Feeney M, Morrissey D, Thornton G, Fitzgerald G, Daly
C, Kiely B, Quigley EMM, O’ Sullvan GC, Shanahan
F, Collins JK, (1999). Probiotics: From myth to reality.
Demonstration of functionality in animal models of disease
and in human clinical trials. Antonie van Leeuwenhoek.
76, 279-292.
5. Ezema C, (2013). Probiotics in animal production: A review.
J Vet Med Anim Health. 5(11), 308-316.
6. Fox SM, (1988). Probiotics: intestinal inoculants for production
animals. Vet Med. 83, 806-830.
7. Fuller R, (1989). A review. Probiotics in man and animals. J
Appl Bacteriol. 66, 365-378.
8. Fuller R, (2004). Reasons for the apparent variation in the
probiotic response. Biologist. 51(4), 232.
9. Gibson GR, Roberfroid M, (1995). Dietary modulation of
the human colonic microbiota: introducing the concept of
prebiotics. J Nutr. 125, 1401-1412.
10. Gilliand SE, (1984). Importance of bile tolerance of
Lactobacillus acidophilus used as a dietary. J Dairy Sci. 67,
3045-3051.
11. Gönç S, Akalın A, (1995). Yoğurtta canlı olarak bulunan
Lactobacillus acidophilus ve Lactobacillus bifidus’un organizma
ve sağlık üzerine etkisi. İzmir, Proje No: VHAG-
1168.
12. Hirayama K, Rafter J, (1999). The role of lactic acid bacteria
in colon cancer prevention: mechanistic considerations.
Antonie van Leewenhoek, 76, 391- 394.
13. Kim CJ, Namkung H, An MS, Paik IK, (1988).
Supplementation of probiotics to the broiler diets containing
moldy corn. Korean J Anim Sci. 30, 542-548.
14. Kognoff MF, (1993). Immunology of the intestinal tract.
Gastroenterol. 105, 1275-1280.
15. Kung L, (1990). Microbes and enzymes. Feed Int. 11(8),
10-16.
16. Leroy F, deVuyst L, (2004). Lactic acid bacteria as functional
starter cultures for the food fermentation industry.
Trend Food Sci Technol. 15, 67-78
17. Marteau P, Minekus M, Havenoar R, Veld JHJ, (1997).
Survival of lactic acid bacteria in a dynamic model of the
stomach and small intestine: Validation and the effects of
bile. J Dairy Sci. 80, 1031-1037.
18. Mattila-Sandholm T, Matto J, Saarela M, (1999). Lactic
acid bacteria with health claims- interactions and interference
with gastrointestinal flora. Int Dairy J. 9, 25-35.
19. Mombelli B, Gismondo MR, (2000). The use of probiotics
in medical practise. Antimicrob Agent Chemother. 16,
531-536.
20. Ouwehand AC, Kirjavainen PV, Shortt C, (1999).
Probiotics: mechanisms and established effects. Int Dairy
J. 9, 43-52.
21. Rastall RA, Gibson GR, Gill HS, (2005). Modulation of the
microbial ecology of the human colon by probiotics, prebiotics
and synbiotics to enhance human health: An over122
view of enabling science and potential applications. FEMS
Microbiol Ecol. 52, 145-152.
22. Salminen S, vonWrigt A, (1998). Current probiotics- safety
assured? Microbial Ecol Health Dis. 10, 68-77.
24. Saxelin M, Tynkkynen S, Mattila-Sandholm T, (2005).
Probiotic and other functional microbes: from markets to
mechanisms. Current Opin Biotechnol. 16, 204-211.
25. Schrezenmeir J, de Vrese M, (2001). Probiotics, prebiotics,
and synbiotics-approaching a definition. Am J Clin Nutr.
73(2 Suppl), 361S-364S.
26. Servin AL, Coconnier MH, (2003). Adhesion of probiotic
strains to the intestinal mucosa and interaction with pathogens.
Best Pract Res Clin Gastroenterol. 17(5), 741-754.
27. Tannock GW, (1997). Probiotic properties of lactic acid
bacteria: plenty of scope for fundamental R&D. Tibtech.
15, 270-274.
28. Vanbelle N, Teller E, Focant M, (1990). Probiotics in animal
nutrition: a review. Arch Anim Nutr. 40, 543-567.
29. Williams GM, Wynder EL, (1996). Diet and cancer: A synopsis
of causes and prevention stratagies. In ‘Nutrition and
Press, Inc., Boca Raton, Fla.
30. Yıldırım Z, Yıldırım M, (2000). Probiyotik özellik gösteren
bifidobakteriler. Süt ve Süt Ürünleri Sempozyumu (Ed. M.
Demirci), Tekirdağ, 266-271.
31. Yılsay TÖ, Kurdal E, (2000). Probiyotik süt ürünlerinin
beslenme ve sağlık üzerindeki etkisi. VI. Süt ve Süt Ürünleri
Sempozyumu (Ed. M. Demirci), Tekirdağ, 279-286.
32. Zhou JS, Shu Q, Rutherfurd KJ, Prasad J, Birtles MJ, Gopal
PK, Gill HS, (2000). Safety assessment of potential probiotic
lactic asid bacterial strains Lactobacillus rhamnosus
HN001, L. acidophilus HN017, and Bifidobacterium lactis
HN019 in BALB/ c mice. Int J Food Microbiol. 56, 87-96.
Year 2016,
Volume: 27 Issue: 2, 118 - 122, 15.12.2016
1. Başyiğit G, (2004). Bazı laktik asit bakterilerinin probiyotik
olarak kullanılma özellikleri. Süleyman Demirel
Üniversitesi Fen Bilimleri Enstitüsü Gıda Mühendisliği
Anabilim Dalı Yüksek Lisans Tezi, 96s, Isparta.
2. Castagliuolo LM, Riegler MF, Valenick I, La Mont JT,
Pathoulakis C, (1999). Saccharomyces boulardii; protease
inhibits the effects of Clostridium difficile toxins A and B in
human colonic mucosa. Infect Immun. 67, 302-307.
3. Douglas LC, Sanders ME, (2008). Probiotics and prebiotics
in dietetics practice. J Am Dietetic Assoc. 108, 510-521.
4. Dunne C, Murphy L, Flynn S, O’Mahony L, O’Halloran S,
Feeney M, Morrissey D, Thornton G, Fitzgerald G, Daly
C, Kiely B, Quigley EMM, O’ Sullvan GC, Shanahan
F, Collins JK, (1999). Probiotics: From myth to reality.
Demonstration of functionality in animal models of disease
and in human clinical trials. Antonie van Leeuwenhoek.
76, 279-292.
5. Ezema C, (2013). Probiotics in animal production: A review.
J Vet Med Anim Health. 5(11), 308-316.
6. Fox SM, (1988). Probiotics: intestinal inoculants for production
animals. Vet Med. 83, 806-830.
7. Fuller R, (1989). A review. Probiotics in man and animals. J
Appl Bacteriol. 66, 365-378.
8. Fuller R, (2004). Reasons for the apparent variation in the
probiotic response. Biologist. 51(4), 232.
9. Gibson GR, Roberfroid M, (1995). Dietary modulation of
the human colonic microbiota: introducing the concept of
prebiotics. J Nutr. 125, 1401-1412.
10. Gilliand SE, (1984). Importance of bile tolerance of
Lactobacillus acidophilus used as a dietary. J Dairy Sci. 67,
3045-3051.
11. Gönç S, Akalın A, (1995). Yoğurtta canlı olarak bulunan
Lactobacillus acidophilus ve Lactobacillus bifidus’un organizma
ve sağlık üzerine etkisi. İzmir, Proje No: VHAG-
1168.
12. Hirayama K, Rafter J, (1999). The role of lactic acid bacteria
in colon cancer prevention: mechanistic considerations.
Antonie van Leewenhoek, 76, 391- 394.
13. Kim CJ, Namkung H, An MS, Paik IK, (1988).
Supplementation of probiotics to the broiler diets containing
moldy corn. Korean J Anim Sci. 30, 542-548.
14. Kognoff MF, (1993). Immunology of the intestinal tract.
Gastroenterol. 105, 1275-1280.
15. Kung L, (1990). Microbes and enzymes. Feed Int. 11(8),
10-16.
16. Leroy F, deVuyst L, (2004). Lactic acid bacteria as functional
starter cultures for the food fermentation industry.
Trend Food Sci Technol. 15, 67-78
17. Marteau P, Minekus M, Havenoar R, Veld JHJ, (1997).
Survival of lactic acid bacteria in a dynamic model of the
stomach and small intestine: Validation and the effects of
bile. J Dairy Sci. 80, 1031-1037.
18. Mattila-Sandholm T, Matto J, Saarela M, (1999). Lactic
acid bacteria with health claims- interactions and interference
with gastrointestinal flora. Int Dairy J. 9, 25-35.
19. Mombelli B, Gismondo MR, (2000). The use of probiotics
in medical practise. Antimicrob Agent Chemother. 16,
531-536.
20. Ouwehand AC, Kirjavainen PV, Shortt C, (1999).
Probiotics: mechanisms and established effects. Int Dairy
J. 9, 43-52.
21. Rastall RA, Gibson GR, Gill HS, (2005). Modulation of the
microbial ecology of the human colon by probiotics, prebiotics
and synbiotics to enhance human health: An over122
view of enabling science and potential applications. FEMS
Microbiol Ecol. 52, 145-152.
22. Salminen S, vonWrigt A, (1998). Current probiotics- safety
assured? Microbial Ecol Health Dis. 10, 68-77.
24. Saxelin M, Tynkkynen S, Mattila-Sandholm T, (2005).
Probiotic and other functional microbes: from markets to
mechanisms. Current Opin Biotechnol. 16, 204-211.
25. Schrezenmeir J, de Vrese M, (2001). Probiotics, prebiotics,
and synbiotics-approaching a definition. Am J Clin Nutr.
73(2 Suppl), 361S-364S.
26. Servin AL, Coconnier MH, (2003). Adhesion of probiotic
strains to the intestinal mucosa and interaction with pathogens.
Best Pract Res Clin Gastroenterol. 17(5), 741-754.
27. Tannock GW, (1997). Probiotic properties of lactic acid
bacteria: plenty of scope for fundamental R&D. Tibtech.
15, 270-274.
28. Vanbelle N, Teller E, Focant M, (1990). Probiotics in animal
nutrition: a review. Arch Anim Nutr. 40, 543-567.
29. Williams GM, Wynder EL, (1996). Diet and cancer: A synopsis
of causes and prevention stratagies. In ‘Nutrition and
Press, Inc., Boca Raton, Fla.
30. Yıldırım Z, Yıldırım M, (2000). Probiyotik özellik gösteren
bifidobakteriler. Süt ve Süt Ürünleri Sempozyumu (Ed. M.
Demirci), Tekirdağ, 266-271.
31. Yılsay TÖ, Kurdal E, (2000). Probiyotik süt ürünlerinin
beslenme ve sağlık üzerindeki etkisi. VI. Süt ve Süt Ürünleri
Sempozyumu (Ed. M. Demirci), Tekirdağ, 279-286.
32. Zhou JS, Shu Q, Rutherfurd KJ, Prasad J, Birtles MJ, Gopal
PK, Gill HS, (2000). Safety assessment of potential probiotic
lactic asid bacterial strains Lactobacillus rhamnosus
HN001, L. acidophilus HN017, and Bifidobacterium lactis
HN019 in BALB/ c mice. Int J Food Microbiol. 56, 87-96.
Koçak, Y., Fındık, A., & Çiftçi, A. (2016). Probiyotikler: Genel Özellikleri ve Güvenilirlikleri. Etlik Veteriner Mikrobiyoloji Dergisi, 27(2), 118-122. https://doi.org/10.35864/evmd.515965